Skip to Main Content

Paper Details

Dual Advanced Therapies and Novel Pharmacotherapies for Moderately to Severely Active Crohn's Disease.
Gastroenterol Clin North Am
0
2022
Author NameAffiliation
Parambir S DulaiUniversity of California
  • 1 - 1

Datasets

Release 1.2